Part 2 Why are IV Drugs so Expensive
Part Two- The cost of the Drug
Now as for the actual cost of the drug! There are "brand names" and there are "generics". The brand named drug is the first to hit the market, and is protected for a number of years to allow the manufacturer to recoup it’s development costs. At times a drug may cost 98 cents, but the company will charge $4,000.00 for a dose of that drug. Wow, that’s a lot of profit.
But the manufacturer has to test the drug and prove to the FDA that the drug is not only safe, but effective. That procedure is lengthy and very costly. The last time I looked (several years ago) the cost averaged a half billion dollars! Five hundred million dollars to prove that a drug is not only safe but also effective. Our company has been involved in drug testing, and quite frankly the procedure is complex and very detailed and extremely expensive. There are pharmacists, nurses, research coordinators, and monitors to insure everything is accurate and proper and that every detail is recorded. The work that goes into the research is incredible complex. There are lab tests to be performed, physician examinations, inspections of the facilities that distribute the drug, as well as the delivery systems. An incredibly complex system to insure safety and that the drug does what the people who sell it claim it does.
Ah but the patent protection does run out and that’s when we see generics enter the supply stream. We recently saw that with Rocephin. We watched the average wholesale price drop from $110.00 per 2 gm for the brand named products to less than $20.00 for the generic. Does that mean the generic is inferior? Not always! Some brand name companies also make generics. Novartis, as an example, is a company that does research and has several brand named products. One division of that company (Sandoz) produces generics. So you have a company that makes brand named products, also producing a generic. (I like to think of it, as another brand, like "Chevy" and "Cadillac") But you could also get a Yugo! You know that car company,, sometimes you go, sometimes you don’t! Sorry I don’t want to disparage a car company but I wanted to make a point. When we purchase generics, we strive to get the most quality for the least dollars. And when there is a company that we don’t know, we mix the drug and send it to an independent lab for testing to make sure it’s not substandard. (This also is costly, somewhere in the neighborhood of one hundred dollars per sample, depending on the product)
Well, you might think, all generics are created equal. Since the FDA inspects each manufacturer, we should buy the cheapest we can find.
I don’t want to give you the idea that there is certain uniformity in drugs such that they are all equal. (while it’s true, many are, some are different) When generics were first introduced there was an anti-diabetic generic drug sold only in Canada for a fraction of the trade named product. The drug was chemically identical to the trade name product and several US citizens purchased the drug from Canada. At first there was no problem, the diabetics blood sugars were in control. But all of a sudden the patients who purchased those generics, had blood sugars out of control and no one could figure out why.
When the generic tablets were analyzed they were chemically identical. It was a puzzle, until someone noticed the problematic tablets were slightly smaller than normal even though they contained the same amount of drug! On further analysis it was found the tablet didn’t dissolve in a normal way. What they found was, the tablet press used to stamp out tablets was set to a pressure that was too hard. The tablets were slightly smaller (because excess pressure was used to stamp out the tablet) and as a consequence they didn’t dissolve properly when patients took them. On further examination, they were found whole in the stool of many patients who were having blood sugar problems.
The above illustration explains why we send off samples of our products to an independent lab for testing. It’s also interesting to note that in our pharmacy we take a small sample of every single IV we produce and put it in a soy broth. (a nutrient solution) and then put it in an incubator. We do this to insure sterility. If bacteria won’t grow in a nutrient broth that is kept at a warm temperature, it assures us that it most probably is bacteria free. This is not a "requirement" or "standard of practice" but we do it to insure sterility of all our products. There are some accreditation agencies that suggest the type of sampling we do be performed daily, or weekly to insure proper procedure but we do it with every sample.
Now what has all of this to do with cost? Simply this, it’s time consuming to do the testing we do, and it’s expensive. And while we want to keep the cost to a bare minimum, we will not compromise quality.
There are other factors affecting the cost of the IV product and that is method of delivery. It’s interesting that even in the delivery system there are a wide range of costs and this too is enormously complex and confusing. Some of the complexity comes from the fact that certain delivery systems are very expensive, but save costs in other places.
For example, an elastomeric pump costs much more than an IV bag. But, a 50 ml bag of normal saline costs about the same as a liter bag with 20 times the volume. (actually the Liter bag costs twice what a 50 ml bag cost, but you get 20 times the volume for twice the price) So you can fill 10 ball pumps with 50 ml for the same cost as 1 IV bag. Then the ball pump comes with its own IV line that you would have had to purchase if you use an IV bag. When you add all of these costs and compare the price can be only slightly more! But, sometimes the seemingly more expense method of deliver is actually the same price or cheaper we have to do the calculation every time to make sure we deliver to our customer the most cost effective product. Other factors such as shipping method also play a roll in cost. It’s much more expensive to ship overnight than ground (which takes several days) If we use ball pumps we must ship overnight (very expensive), but if we use connectors where the product is simply connected to diluent but not mixed, we can ship ground (much less expensive). But the connectors add extra expense! As you can see, the calculations are very complex.
Some patients want to IV push a drug, and that is very inexpensive because you don’t have to use IV lines, have a pump etc. etc. etc. etc. But some drugs can’t be IV pushed because they can do damage when that route of administration is used. So deciding which method of administration is complex! The wrong choice can have financial consequences, but financial outcomes do not take precedence over patient safety.
IV drugs are expensive but they don’t have to be overly costly! Patients should chose their pharmacist as carefully as they chose their physician!
Written by David Kazarian.
David Kazarian has practiced pharmacy for over 4 decades! He as been president of a national pharmacy organization and currently sits on the board of a public company that produces products for the pharmaceutical industry. He has started two IV companies and currently is president of Infuserve America, a home IV company located in Saint Petersburg Florida.
Brought to you by HCC Pharmacy Solutions
Dean A. Pedalino RPh,CPh, FASCP
Now as for the actual cost of the drug! There are "brand names" and there are "generics". The brand named drug is the first to hit the market, and is protected for a number of years to allow the manufacturer to recoup it’s development costs. At times a drug may cost 98 cents, but the company will charge $4,000.00 for a dose of that drug. Wow, that’s a lot of profit.
But the manufacturer has to test the drug and prove to the FDA that the drug is not only safe, but effective. That procedure is lengthy and very costly. The last time I looked (several years ago) the cost averaged a half billion dollars! Five hundred million dollars to prove that a drug is not only safe but also effective. Our company has been involved in drug testing, and quite frankly the procedure is complex and very detailed and extremely expensive. There are pharmacists, nurses, research coordinators, and monitors to insure everything is accurate and proper and that every detail is recorded. The work that goes into the research is incredible complex. There are lab tests to be performed, physician examinations, inspections of the facilities that distribute the drug, as well as the delivery systems. An incredibly complex system to insure safety and that the drug does what the people who sell it claim it does.
Ah but the patent protection does run out and that’s when we see generics enter the supply stream. We recently saw that with Rocephin. We watched the average wholesale price drop from $110.00 per 2 gm for the brand named products to less than $20.00 for the generic. Does that mean the generic is inferior? Not always! Some brand name companies also make generics. Novartis, as an example, is a company that does research and has several brand named products. One division of that company (Sandoz) produces generics. So you have a company that makes brand named products, also producing a generic. (I like to think of it, as another brand, like "Chevy" and "Cadillac") But you could also get a Yugo! You know that car company,, sometimes you go, sometimes you don’t! Sorry I don’t want to disparage a car company but I wanted to make a point. When we purchase generics, we strive to get the most quality for the least dollars. And when there is a company that we don’t know, we mix the drug and send it to an independent lab for testing to make sure it’s not substandard. (This also is costly, somewhere in the neighborhood of one hundred dollars per sample, depending on the product)
Well, you might think, all generics are created equal. Since the FDA inspects each manufacturer, we should buy the cheapest we can find.
I don’t want to give you the idea that there is certain uniformity in drugs such that they are all equal. (while it’s true, many are, some are different) When generics were first introduced there was an anti-diabetic generic drug sold only in Canada for a fraction of the trade named product. The drug was chemically identical to the trade name product and several US citizens purchased the drug from Canada. At first there was no problem, the diabetics blood sugars were in control. But all of a sudden the patients who purchased those generics, had blood sugars out of control and no one could figure out why.
When the generic tablets were analyzed they were chemically identical. It was a puzzle, until someone noticed the problematic tablets were slightly smaller than normal even though they contained the same amount of drug! On further analysis it was found the tablet didn’t dissolve in a normal way. What they found was, the tablet press used to stamp out tablets was set to a pressure that was too hard. The tablets were slightly smaller (because excess pressure was used to stamp out the tablet) and as a consequence they didn’t dissolve properly when patients took them. On further examination, they were found whole in the stool of many patients who were having blood sugar problems.
The above illustration explains why we send off samples of our products to an independent lab for testing. It’s also interesting to note that in our pharmacy we take a small sample of every single IV we produce and put it in a soy broth. (a nutrient solution) and then put it in an incubator. We do this to insure sterility. If bacteria won’t grow in a nutrient broth that is kept at a warm temperature, it assures us that it most probably is bacteria free. This is not a "requirement" or "standard of practice" but we do it to insure sterility of all our products. There are some accreditation agencies that suggest the type of sampling we do be performed daily, or weekly to insure proper procedure but we do it with every sample.
Now what has all of this to do with cost? Simply this, it’s time consuming to do the testing we do, and it’s expensive. And while we want to keep the cost to a bare minimum, we will not compromise quality.
There are other factors affecting the cost of the IV product and that is method of delivery. It’s interesting that even in the delivery system there are a wide range of costs and this too is enormously complex and confusing. Some of the complexity comes from the fact that certain delivery systems are very expensive, but save costs in other places.
For example, an elastomeric pump costs much more than an IV bag. But, a 50 ml bag of normal saline costs about the same as a liter bag with 20 times the volume. (actually the Liter bag costs twice what a 50 ml bag cost, but you get 20 times the volume for twice the price) So you can fill 10 ball pumps with 50 ml for the same cost as 1 IV bag. Then the ball pump comes with its own IV line that you would have had to purchase if you use an IV bag. When you add all of these costs and compare the price can be only slightly more! But, sometimes the seemingly more expense method of deliver is actually the same price or cheaper we have to do the calculation every time to make sure we deliver to our customer the most cost effective product. Other factors such as shipping method also play a roll in cost. It’s much more expensive to ship overnight than ground (which takes several days) If we use ball pumps we must ship overnight (very expensive), but if we use connectors where the product is simply connected to diluent but not mixed, we can ship ground (much less expensive). But the connectors add extra expense! As you can see, the calculations are very complex.
Some patients want to IV push a drug, and that is very inexpensive because you don’t have to use IV lines, have a pump etc. etc. etc. etc. But some drugs can’t be IV pushed because they can do damage when that route of administration is used. So deciding which method of administration is complex! The wrong choice can have financial consequences, but financial outcomes do not take precedence over patient safety.
IV drugs are expensive but they don’t have to be overly costly! Patients should chose their pharmacist as carefully as they chose their physician!
Written by David Kazarian.
David Kazarian has practiced pharmacy for over 4 decades! He as been president of a national pharmacy organization and currently sits on the board of a public company that produces products for the pharmaceutical industry. He has started two IV companies and currently is president of Infuserve America, a home IV company located in Saint Petersburg Florida.
Brought to you by HCC Pharmacy Solutions
Dean A. Pedalino RPh,CPh, FASCP
Labels: Specialty Pharmacy articles
